India currently does not have any XBB 1.5 variant-based vaccines available. IMAGE: A healthcare worker prepares a dose of a COVID-19 vaccine. Photograph: ANI Photo New-generation Covid......
In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its COVID vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the......
A team of scientists from the world's leading universities has developed a new all-in-one vaccine that they hope can protect humans against a broad range of coronaviruses, including ones that are......
United Kingdom-headquartered pharmaceutical giant AstraZeneca (AZ) has admitted that in 'very rare cases' its Covid vaccine can cause a blood clot related side effect but the causal link is......
The Oxford-AstraZeneca COVID-19 vaccine, known as Vaxzevria in Europe and licensed as Covishield in India, is facing a legal challenge in the high court in London, a UK media report said on......
Serum Institute of India chief Adar Poonawalla will pay £138 million (about Rs 1,444 crore) for a Mayfair mansion in London in one of the city’s most expensive home sales of the year,......
Prime Minister Narendra Modi and his British counterpart Boris Johnson on Tuesday unveiled a 'Roadmap 2030' to elevate the India-UK ties to a comprehensive strategic level, and declared an enhanced......